Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 176
Filtrar
4.
J Environ Manage ; 342: 118332, 2023 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-37315463

RESUMEN

Passively aerated biological pretreatment was applied to four different lignocellulosic biomasses with varying fiber content profiles: sugar beet pulp (SBP), brewery bagasse (BB), rice husk (RH), and orange peel (OP). In order to analyze the organic matter solubilization yield at 24 and 48 h, different percentages of activated sewage sludge (2.5-10%) were utilized as inoculum. The OP achieved the best organic matter solubilization yield in terms of soluble chemical oxygen demand (sCOD) and dissolved organic carbon (DOC) at 2.5% inoculation and 24 h: 58.6% and 20%, respectively, since some total reducing sugars (TRS) consumption was identified after 24 h. On the contrary, the worst organic matter solubilization yield was obtained with RH, the substrate with the highest lignin content among the tested, with percentages of 3.6% and 0.7% in terms of sCOD and DOC respectively. In fact, it could be considered that this pretreatment was not successful with RH. The optimum inoculation proportion was 7.5% (v/v) except for the OP (2.5% (v/v)). Finally, due to the counterproductive organic matter consumption at longer pretreatment durations, the optimal time for BB, SBP, and OP was 24 h.


Asunto(s)
Beta vulgaris , Oryza , Biomasa , Lignina , Materia Orgánica Disuelta , Aguas del Alcantarillado/química
6.
Rev. esp. cardiol. (Ed. impr.) ; 75(10): 834-842, oct. 2022.
Artículo en Español | IBECS | ID: ibc-211055

RESUMEN

La publicación del estudio EMPEROR-Preserved y la extensión del beneficio cardiovascular de los inhibidores del cotransportador de sodio-glucosa tipo 2 (iSGLT2) a pacientes con insuficiencia cardiaca IC y fracción de eyección (FE)> 40% supone un importante hito en el tratamiento de la IC con FE conservada (IC-FEc). A raíz de estos resultados, en febrero de 2022 la Food and Drug Administration estadounidense aprobó el uso de la empagliflozina para el tratamiento de pacientes con IC independientemente de la FE. Sin embargo, un análisis más detallado del estudio EMPEROR-Preserved genera ciertas dudas en relación con la banda de FE más alta (> 60%). Este grupo de pacientes presenta una gran heterogeneidad y probablemente no se pueda considerar un único fenotipo para fines terapéuticos y de abordaje clínico. Además, la FE es un parámetro continuo. Por ello, no parece que una diferenciación basada en puntos de corte matemáticos concuerde con la evidencia más reciente, que apunta precisamente a un cambio más gradual en cuanto a mecanismos subyacentes, etiologías y respuesta al tratamiento a lo largo del espectro de la FE. Un mejor conocimiento de los mecanismos fisiopatológicos es fundamental para establecer nuevas dianas terapéuticas, interpretar los resultados de los ensayos clínicos y desarrollar tratamientos dirigidos y eficaces (AU)


The publication of the EMPEROR-Preserved trial and data on the benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with heart failure (HF) with ejection fraction (EF)> 40% represent a significant step forward in the treatment of HF with preserved EF. Given these results, in February 2022 the US Food and Drug Administration approved the use of empaglifozin in adults with HF with reduced or preserved EF. However, more detailed analysis of the EMPEROR-Preserved trial led to doubts about the effect of empagliflozin in patients with an EF of> 60% this patient group is widely heterogeneous and, probably, a single phenotype cannot be considered in treatment goals or the clinical approach. Moreover, EF occurs on a continuum and classifications of HF according to arbitrary cut-points in EF do not appear consistent with recent evidence, which points to a gradual shift and considerable overlap in underlying mechanisms, phenotypes and treatment response over the spectrum of EF. Enhanced knowledge of pathophysiological mechanisms is essential to establish new therapeutic targets, interpret the results of clinical trials, and develop targeted and effective therapies (AU)


Asunto(s)
Humanos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insuficiencia Cardíaca/tratamiento farmacológico , Proteínas de Transporte de Sodio-Glucosa/uso terapéutico , Volumen Sistólico
7.
Rev. cir. (Impr.) ; 73(6): 718-727, dic. 2021. tab, graf
Artículo en Español | LILACS | ID: biblio-1388888

RESUMEN

Resumen Introducción: La pandemia COVID-19 generó una reestructuración en la atención quirúrgica mundialmente debido a su alta transmisibilidad y la inherente limitación de los recursos humanos y materiales disponibles. Objetivo: Describir el impacto de la pandemia COVID-19 en el Equipo de Cirugía Cabeza y Cuello del Complejo Asistencial Barros Luco Trudeau (CABL) en su ejecución clínico-quirúrgica y la secuenciación organizada de las medidas sanitarias aplicadas a lo largo del tiempo durante los primeros 150 días de iniciada la pandemia en Chile. Materiales y Método: Realizamos una revisión retrospectiva de los pacientes sometidos a cirugía y/o evaluados ambulatoriamente durante el período COVID-19 comprendido entre el 3 de marzo y el 31 de julio de 2020, comparado con el mismo intervalo de tiempo de 2019. Características clínicas y medidas sanitarias empleadas durante este período fueron sintetizadas. Resultados: Detectamos un descenso del 64% en atención ambulatoria y un descenso del 58% en la carga quirúrgica, comparado con el año 2019. Durante el período COVID-19 de 2020, un total de 61 pacientes fueron sometidos a intervención quirúrgica. La principal indicación de cirugía fue cáncer en un 75,4% (46). No se reportaron pacientes contagiados por COVID-19 en los 14 días siguientes a la hospitalización. Se discuten las consideraciones perioperatorias empleadas y restricciones nacionales/institucionales sanitarias. Conclusión: La crisis sanitaria mundial secundaria al COVID-19 generó una reducción en las atenciones ambulatorias y cirugías realizadas por Equipo de Cabeza y Cuello CABL. A pesar de las restricciones sanitarias, organizamos estratificadamente la atención para preservar la resolución de casos críticos no diferibles en cabeza y cuello.


Introduction: The COVID-19 pandemic generated a restructuring of surgical care worldwide due to the disease's high transmissibility and the inherent limitation of available human and material resources. Aim: The study's aim was to describe the impact of the COVID-19 pandemic on the head and neck surgery team at Complejo Asistencial Barros Luco Trudeau (CABL) in clinical-surgical execution and organization of sanitary sequencing measures implemented over time during the first 150 days after the pandemic started in Chile. Materials and Method: We performed a retrospective review of patients undergoing surgery or outpatient evaluation during the COVID-19 period from 03-03-2020 to 07-31-2020, compared to the same time interval in 2019. Clinical characteristics and sanitary measures used during this period were synthesized. Results: We detected a 64% decrease in outpatient care and a 58% decrease in surgical load from 2019. During the COVID-19 period of 2020, a total of 61 patients underwent surgical intervention. The main indication for surgery was cancer, in 75.4% of patients (46). COVID-19 was not reported in any patients in the 14 days following hospitalization. We discussed the perioperative considerations used and the national/institutional sanitary restrictions. Conclusions: The global health crisis to COVID-19 generated a reduction in outpatient care and surgeries performed by the CABL head and neck team. Despite health restrictions, we organized care stratified to preserve critical head and neck non-deferrable cases.


Asunto(s)
Humanos , Pandemias , COVID-19 , Neoplasias de Cabeza y Cuello/cirugía , SARS-CoV-2 , Directrices para la Planificación en Salud , Política de Salud , Oncología Médica
8.
Arch. Soc. Esp. Oftalmol ; 96(11): 587-592, nov. 2021. tab
Artículo en Español | IBECS | ID: ibc-218283

RESUMEN

Propósito Analizar los datos clínicos de pacientes con uveítis anteriores agudas hipertensivas HLA-B27 negativas. Se obtuvieron muestras de humor acuoso, en las que se realizó reacción en cadena de la polimerasa (PCR), y se clasificaron los pacientes en 3 grupos según las muestras fueran positivas para citomegalovirus (CMV), virus herpes (VHS-VVZ) o negativas para ambos. Material y métodos En los 3 grupos de pacientes se recogieron las variables edad, sexo, agudeza visual, presión intraocular (PIO), células en cámara anterior, precipitados retroqueráticos, tratamiento hipotensor, cirugía de glaucoma, retina o trasplante corneal y grosor central de la capa de fibras nerviosas de la retina. Todas las variables fueron recogidas en la visita basal y a los 3, 6 y 12 meses. Resultados Se incluyeron 36 pacientes, con una edad media de 59,78±15,26 años. El valor medio basal de PIO fue 40±10,42mmHg en el grupo CMV frente a 23,8±10,4mmHg en el VHS-VVZ y 22,65±9,9mmHg en el grupo PCR negativo. La frecuencia basal de precipitados retroqueráticos, tratamiento hipotensor, cirugía de glaucoma y trasplante corneal fue mayor en los positivos para CMV. Sin embargo, al año la pérdida de capa de fibras nerviosas de la retina y la tasa de cirugía de glaucoma fue mayor en el grupo PCR negativo. Durante el seguimiento, en los 3 grupos hubo correlación directa y positiva entre la PIO y la inflamación en cámara anterior. Esta correlación fue de 0,94 (p=0,05) para el positivo para CMV, de 0,24 (p=0,75) en el de VHS-VVZ y de 0,98 (p=0,17) en el negativo. Conclusiones Las uveítis anteriores agudas hipertensivas HLA-B27 negativas con PCR de humor acuoso positiva para CMV tienen una presentación más agresiva inicialmente; sin embargo, al año de seguimiento el daño glaucomatoso es menor que en aquellas con PCR negativa. En las uveítis anteriores agudas hipertensivas, cuando, con el tratamiento oportuno, se controla la inflamación en cámara anterior, se controla la PIO (AU)


Purpose To perform a retrospective analysis on patients with HLA-B27 negative hypertensive acute anterior uveitis. Aqueous humor samples were obtained on which a polymerase chain reaction (PCR) test was performed. The patients were then classified into 3 groups depending on whether they were positive for cytomegalovirus (CMV) or herpesvirus (HSV-VZV) or negative for both. Material and methods Different variables were collected in successive visits (baseline, 3, 6, and 12 months). The variables were age, sex, visual acuity, intraocular pressure (IOP), cells in the anterior chamber, retro-keratic precipitates, hypotensive treatment, glaucoma or retina surgery, corneal transplantation, and central thickness of the retinal nerve fiber layer. Results The sample was 36 patients, with a mean age of 59.78±15.26 years. The mean baseline IOP value was 40±10.42mmHg in the CMV group compared to 23.8±10.4mmHg in the HSV-VZV, and 22.65±9.9mmHg in the negative group. The baseline frequency of retro-keratic precipitates, hypotensive treatment, glaucoma surgery, and corneal transplantation was higher in CMV positives. At one year, the loss of retinal nerve fiber layer and glaucoma surgery was greater in the negative group. In the 3 groups, there was a direct and positive correlation between IOP and inflammation in the anterior chamber. Being 0.94 (P=.05) for the positive for CMV, 0.24 (P=.75) in that of HSV-VZV, and 0.98 (P=.17) in the negative group. Conclusions HLA-B27 negative hypertensive acute anterior uveitis with CMV positive has a more aggressive initial presentation. However, after one year, the glaucomatous damage is less than in the negative group. In hypertensive acute anterior uveitis, when inflammation in anterior chamber is controlled then IOP is also controlled (AU)


Asunto(s)
Humanos , Masculino , Femenino , Uveítis/virología , Infecciones por Citomegalovirus/complicaciones , Infecciones por Herpesviridae/complicaciones , Hipertensión Ocular , Reacción en Cadena de la Polimerasa , Estudios Retrospectivos , Enfermedad Aguda
9.
Arch Soc Esp Oftalmol (Engl Ed) ; 96(11): 587-592, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34756280

RESUMEN

PURPOSE: To perform a retrospective analysis on patients with HLA-B27 negative hypertensive acute anterior uveitis. Aqueous humor samples were obtained on which a polymerase chain reaction (PCR) test was performed. The patients were then classified into 3 groups depending on whether they were positive for cytomegalovirus (CMV) or herpesvirus (HSV-VZV) or negative for both. MATERIAL AND METHODS: Different variables were collected in successive visits (baseline, 3, 6, and 12 months). The variables were age, sex, visual acuity, intraocular pressure (IOP), cells in the anterior chamber, retro-keratic precipitates, hypotensive treatment, glaucoma or retina surgery, corneal transplantation, and central thickness of the retinal nerve fiber layer. RESULTS: The sample was 36 patients, with a mean age of 59.78 ± 15.26 years. The mean baseline IOP value was 40 ± 10.42 mmHg in the CMV group compared to 23.8 ± 10.4 mmHg in the HSV-VZV, and 22.65 ± 9.9 mmHg in the negative group. The baseline frequency of retro-keratic precipitates, hypotensive treatment, glaucoma surgery, and corneal transplantation was higher in CMV positives. At one year, the loss of retinal nerve fiber layer and glaucoma surgery was greater in the negative group. In the 3 groups, there was a direct and positive correlation between IOP and inflammation in the anterior chamber. Being 0.94 (P = .05) for the positive for CMV, 0.24 (P = .75) in that of HSV-VZV, and 0.98 (P = .17) in the negative group. CONCLUSIONS: HLA-B27 negative hypertensive acute anterior uveitis with CMV positive has a more aggressive initial presentation. However, after one year, the glaucomatous damage is less than in the negative group. In hypertensive acute anterior uveitis, when inflammation in anterior chamber is controlled then IOP is also controlled.


Asunto(s)
Uveítis Anterior , Uveítis , Adulto , Anciano , Citomegalovirus , Antígeno HLA-B27/genética , Humanos , Persona de Mediana Edad , Estudios Retrospectivos
10.
Ethique Sante ; 18(4): 217-223, 2021 Dec.
Artículo en Francés | MEDLINE | ID: mdl-34493941

RESUMEN

The Covid-19 pandemic instills emotions that can be understood in the pathological sense of mental disorder and/or in the heuristic sense of a moral dimension. So what about this distinction in critical care and resuscitation services where caregivers are at the forefront of events? What to do with emotions? The objective of this work is to pose a medico-psychological and ethical perspective on these questions, starting from the hypothesis that emotions have a specific use during the pandemic. The first step will be to show that anguish and fear, although different from an epistemological point of view, arise from the same historical place, which is the discourse of the medical world with death. The awareness of the inevitable makes share the same need of the caregiver and the citizen of a psychic economy which will lead to differentiating two possible reactions to emotions: one to face up and one to come to terms with. This psychic interlacing, inherent to the pandemic context, calls for critical care on a moral dimension related to the issue of abandonment of the human person and the poorly understood notion of "mass death". An answer to this difficulty would be found in the concept of "being-caregiver-close" but its application also supposes an ethical reflection on the outlets and the personal virtues.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA